Marrone Bio Innovations, Inc. Debt to Equity Ratio 2013-2022 | MBII
Current and historical debt to equity ratio values for Marrone Bio Innovations, Inc. (MBII) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Marrone Bio Innovations, Inc. debt/equity for the three months ending March 31, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-03-31 |
$0.05B |
$0.02B |
2.33 |
2021-12-31 |
$0.06B |
$0.03B |
1.94 |
2021-09-30 |
$0.05B |
$0.03B |
1.68 |
2021-06-30 |
$0.05B |
$0.04B |
1.47 |
2021-03-31 |
$0.05B |
$0.04B |
1.45 |
2020-12-31 |
$0.05B |
$0.03B |
1.59 |
2020-09-30 |
$0.05B |
$0.02B |
2.12 |
2020-06-30 |
$0.05B |
$0.03B |
2.00 |
2020-03-31 |
$0.06B |
$0.03B |
2.19 |
2019-12-31 |
$0.05B |
$0.02B |
2.09 |
2019-09-30 |
$0.05B |
$0.03B |
2.19 |
2019-06-30 |
$0.04B |
$0.00B |
12.54 |
2019-03-31 |
$0.04B |
$0.01B |
4.47 |
2018-12-31 |
$0.03B |
$0.01B |
2.60 |
2018-09-30 |
$0.03B |
$0.02B |
1.80 |
2018-06-30 |
$0.03B |
$0.02B |
1.51 |
2018-03-31 |
$0.03B |
$0.01B |
2.49 |
2017-12-31 |
$0.09B |
$-0.05B |
-1.73 |
2017-09-30 |
$0.08B |
$-0.04B |
-1.86 |
2017-06-30 |
$0.08B |
$-0.04B |
-2.34 |
2017-03-31 |
$0.08B |
$-0.04B |
-2.16 |
2016-12-31 |
$0.08B |
$-0.03B |
-2.52 |
2016-09-30 |
$0.07B |
$-0.02B |
-3.16 |
2016-06-30 |
$0.08B |
$-0.02B |
-4.48 |
2016-03-31 |
$0.08B |
$-0.01B |
-7.00 |
2015-12-31 |
$0.07B |
$-0.00B |
-36.21 |
2015-09-30 |
$0.07B |
$0.01B |
8.94 |
2015-06-30 |
$0.04B |
$0.01B |
3.20 |
2015-03-31 |
$0.04B |
$0.02B |
1.83 |
2014-12-31 |
$0.04B |
$0.03B |
1.32 |
2014-09-30 |
$0.00B |
|
0.00 |
2014-06-30 |
$0.04B |
$0.07B |
0.55 |
2014-03-31 |
$0.03B |
$0.03B |
0.87 |
2013-12-31 |
$0.03B |
$0.04B |
0.79 |
2013-09-30 |
$0.03B |
$0.05B |
0.50 |
2013-06-30 |
$0.07B |
$-0.05B |
-1.54 |
2013-03-31 |
$0.06B |
$-0.05B |
-1.40 |
2012-12-31 |
$0.07B |
$-0.04B |
-1.98 |
2012-09-30 |
$0.00B |
|
0.00 |
2012-06-30 |
$0.00B |
|
0.00 |
2012-03-31 |
$0.00B |
|
0.00 |